PH94B + Placebo
Phase 2Completed 0 watching 0 views this week⚡ Active
44
Development Stage
✓
Pre-clinical✓
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Adjustment Disorder With Anxious Mood
Conditions
Adjustment Disorder With Anxious Mood
Trial Timeline
Oct 12, 2021 → Dec 14, 2022
NCT ID
NCT04404192About PH94B + Placebo
PH94B + Placebo is a phase 2 stage product being developed by Vistagen Therapeutics for Adjustment Disorder With Anxious Mood. The current trial status is completed. This product is registered under clinical trial identifier NCT04404192. Target conditions include Adjustment Disorder With Anxious Mood.
Hype Score Breakdown
Clinical
17
Activity
12
Company
2
Novelty
5
Community
5
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT04404192 | Phase 2 | Completed |